Works by Vidarsdottir, Linda


Results: 8
    1
    2
    3

    PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89389-9
    By:
    • Vidarsdottir, Linda;
    • Azimi, Alireza;
    • Das, Ishani;
    • Sigvaldadottir, Ingibjorg;
    • Suryo Rahmanto, Aldwin;
    • Petri, Andreas;
    • Kauppinen, Sakari;
    • Ingvar, Christian;
    • Jönsson, Göran;
    • Olsson, Håkan;
    • Frostvik Stolt, Marianne;
    • Tuominen, Rainer;
    • Sangfelt, Olle;
    • Pokrovskaja Tamm, Katja;
    • Hansson, Johan;
    • Grandér, Dan;
    • Egyházi Brage, Suzanne;
    • Johnsson, Per
    Publication type:
    Article
    4

    Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 12, p. 929, doi. 10.1093/jnci/djm005
    By:
    • Tryggvadóttir, Laufey;
    • Vidarsdóttir, Linda;
    • Thorgeirsson, Tryggvi;
    • Gunnlaugur Jonasson, Jon;
    • Ólafsdóttir, Elinborg Jona;
    • Ólafsdóttir, Gudridur Helga;
    • Rafnar, Thorunn;
    • Thorlacius, Steinunn;
    • Jonsson, Eirikur;
    • Eyfjord, Jorunn Erla;
    • Tulinius, Hrafn
    Publication type:
    Article
    5

    MicroRNA-190b Targets RFWD3 in Estrogen Receptor–Positive Breast Cancer.

    Published in:
    Breast Cancer: Basic & Clinical Research, 2024, p. 1, doi. 10.1177/11782234241234771
    By:
    • Frick, Elisabet Alexandra;
    • Kristjansdottir, Karen;
    • Ragnarsdottir, Snaedís;
    • Vilhjalmsson, Arnar Ingi;
    • Bustos, Maria Rose;
    • Vidarsdottir, Linda;
    • Gudjonsson, Thorkell;
    • Sigurdsson, Stefan
    Publication type:
    Article
    6
    7
    8